- Condition: Solid Tumor
Interventions: Drug: Bevacizumab; Drug: Temozolomide; Drug: Vincristine sulfate; Drug: Irinotecan; Drug: Cefixime or Cefpodoxime
Sponsors: Children's Hospital Medical Center, Cincinnati; Children's Hospital Medical Center, Cincinnati
Recruiting - verified February 2012 - Condition: Neuroblastoma
Intervention: Drug: Irinotecan and Bortezomib
Sponsors: University of Michigan Cancer Center; University of Michigan Cancer Center; Millennium Pharmaceuticals, Inc.
Recruiting - verified July 2011
 |
Cefpodoxime proxetil Clinical Trials |
